One potential mechanism could be that the mutated segments cover specific bladder cancer-related pathogenic genes, such as TP73 [26], KMT2C [27, 28], and FOXA2 [29], or affect some tumor suppressor genes. This evidence concerns the gene KMT2C and urinary bladder carcinoma.